Inhibition of CD95 (Fas/Apo1)-mediated apoptosis by vaccinia virus WR

Clinical and Experimental Immunology

Volumn 103, Issue 1, 1996, Pages 8-14

  Heinkelein, M ^a   Pilz, S ^a   Jassoy, C ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Apo 1; Apoptosis; CD95; Fas; Vaccinia

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN;

APOPTOSIS; ARTICLE; CELL LINE; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS INFECTION;

EID: 0030029445     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.927619.x     Document Type: Article

References (45)

1. Itoh N, Yonehara S, Ishii A et al. The polypeptide encoded by the cDNA for the human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66:233-43.
2. Oehm A, Behrmann I, Falk W et al. Purification and molecular cloning of the Apo-1 cell surface antigen, a member of the tumor necrosis factor nerve growth factor receptor superfamily. J Biol Chem 1992; 267:10709-15.
3. Suda T, Takahashi T, Golstcin F, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75:1169-78.
4. Kägi D, Vignaux F, Ledermann B et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Nature 1994; 265:528-30,
5. Lowin B, Hahne M, Mattmann Ch, Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and the Fas lytic pathway. Nature 1994; 370:650-2.
6. Ju S-T, Panka DJ, Cui H et al. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995; 373:444-8.
7. Krammer PH, Behrmann I, Daniel P, Dhein J, Debatin K-M. Regulation of apoptosis in the immune system. Curr Op Immunol 1994; 6:279-89.
8. Fenner F. The biological characters of several strains of vaccinia, cowpox and rabbitpox viruses. Virology 1958; 5:502-29.
9. Tartaglia J, Perkus MK, Taylor J et al. NYVAC: a highly attenuated strain of vaccinia virus. Virology 1992; 188:217-32.
10. Goebel SJ, Johnson GP, Perkus MF, et al. The complete DNA sequence of vaccinia virus. Virology 1990; 179:247-66.
11. Townsend A, Bastin J, Gould K et al. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med 1988; 168:1211-24.
12. Kotwal GJ, Isaacs SN, McKenzie R, Frank MM, Moss B. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 1990; 250:827-30.
13. Isaacs SN, Kotwal GJ, Moss B. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc Natl Acad Sci USA 1992; 89:628-32.
14. Alcami A, Smith GL. A soluble receptor for interleukin-1β encoded by vaccinia virus: a novel mechanism of virus modulation of the host immune response. Cell 1992; 71:153-67.
15. Ray CA, Black RA, Kronheim SR et al. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell 1992; 69:597-604.
16. Spriggs MK, Hruby DE, Maliszewski ChR et al. Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 1992; 71:145-52.
17. Chang H-W, Watson JC, Jacobs BL. The E3 4 gene of vaccinia virus encodes an inhbitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci USA 1992; 89:4825-9.
18. Upton C, Mossman K, McFadden G. Encoding of a homolog of the IFN-γ receptor by myxoma virus. Science 1992; 258:1369-72.
19. Carroll K, Elroy-Stein O, Moss B, Jagus R. Recombinant vaccinia virus K34 gene product prevents activation of double-stranded RNA-dependent, initiation factor 2α-specitic protein kinase. J Biol Chem 1993; 268:12837-43.
20. Palumbo GJ, Buller RM, Glasgow WC. Multigenic evasion of inflammation by poxviruses. J Virol 1994; 68:1737-49.
21. Schreiber M, McFadden G. The myxoma virus TNF-receptor homologue (T2) inhibits tumor necrosis factor-α in a species-specific fashion. Virology 1994; 204:692-705.
22. Weiss A, Wiskocil RL, Stobo JD. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL2 production reflects events occuring at a pre-translational level. J Immunol 1984; 133:123-8.
23. Folks T, Benn S, Rabson A et al. Characterization of a continous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. Proc Natl Acad Sci USA 1985; 82:4539-43.
24. Drillien R, Spehner D, Kirn A et al. Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or fusion protein. Proc Natl Acad Sci USA 1988; 85:1252-6.
25. Chesebro B, Wehrly K. Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J Virol 1988; 62:3779-88.
26. Jassoy C, Johnson RP, Navia BA, Worth J, Walker BD. Detection of a vigorous HIV-1-specific cytotoxic T-lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. J Immunol 1992; 149:3113-9.
27. McConkey DJ, Aguilar-Santelises M, Hartzell P et al. Induction of DNA fragmentation in chronic B lymphocytic leukemia cells. J Immunol 1991; 146:1072-6.
28. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. J Immunol Methods 1986; 89:271-7.
29. Darzinkiewicz Z, Bruno S, Bino G Del et al. Features of apoptotic cells measured by flow cytometry. Cytometry 1992; 13:795-808.
30. + cytotoxic T cells. Proc Natl Acad Sci USA 1994; 91:4185-9.
31. Ink BS, Gilbert CS, Evan GI. Delay of vaccinia virus-induced apoptosis in nonpermissive chinese hamster ovary cells by the cowpox virus CHOhr and adenovirus E1B 19K genes. J Virol 1995; 69:661-8.
32. Miura M, Zhu H, Rotello R, Hartwieg FA, Yuan J. Induction of apoptosis in fibroplasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced 3. Cell 1993; 75:653-60.
33. Gagliardini V, Fernandez P-A, Lee RKK et al. Prevention of vertebrate neuronal death by the crmA gene. Science 1994; 263:826-8.
34. Enari M, Hug H, Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 1995; 375:78-81.
35. Los M, Craen M van der, Penning LC et al. Requirement of an ICE/ CED-3 protease for Fas/Apo-1-mediated apoptosis. Nature 1995; 375:81-83.
36. Kotwal GJ, Moss B. Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine protease inhibitor superfamily. J Virol 1989; 63:600-6.
37. Hashimoto S, Ishii A, Yonehara S. The E1b oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas antibody. Int Immunology 1991; 3:343-51.
38. Chittenden T, Harrington EA, O'Conner R et al. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 1995; 374:733-6.
39. Debbas M, While F. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1b. Genes Dev 1993; 7:546-54.
40. Subramian T, Tarodi B, Govindarajan R et al. Mutational analysis of the transforming and apoptosis suppression activities of the adenovirus E1B 175R protein. Gene 1993; 124:173-81.
41. Wold WS. Adenovirus genes that modulate the sensitivity of the virus-infected cells to lysis by TNF. J Cell Biochem 1993;53:329-35.
42. Copeland K, Haaksma AGM, Goudsmit J, Krammer PH, Heeney JL. Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I tax. AIDS Res Hum Retrovir 1994; 10:1259-67.
43. Yamada T, Yamaoka S, Goto T et al. The human T-cell leukemia virus type I tax protein induces apoptosis which is blocked by the bcl-2 protein. J Virol 1994; 68:3374-9.
44. Vaux DL, Haecker G, Strasser A. An evolutionary aspect on apoptosis. Cell 1994; 76:777-9.
45. Moss B. Vaccinia virus: a tool for research and vaccine development. Science 1991; 252:1662-7.